NCAM1 and hyperlipidemia: CD3+CD56+ γδ T cells at hyperlipidemia patients with CC, 0.0113 ± 0.0187 x109/L vs 0.0188 ± 0.0267 x109/L without hyperlipidemia, p = 0.015.